185 related articles for article (PubMed ID: 32572551)
1. Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation.
Rivinius R; Helmschrott M; Rahm AK; Darche FF; Thomas D; Bruckner T; Doesch AO; Katus HA; Ehlermann P
Clin Res Cardiol; 2022 Feb; 111(2):141-153. PubMed ID: 32572551
[TBL] [Abstract][Full Text] [Related]
2. Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart.
Rivinius R; Helmschrott M; Ruhparwar A; Rahm AK; Darche FF; Thomas D; Bruckner T; Ehlermann P; Katus HA; Doesch AO
Clin Res Cardiol; 2018 Feb; 107(2):138-147. PubMed ID: 29098378
[TBL] [Abstract][Full Text] [Related]
3. Heart rate reduction for 12 months with ivabradine reduces left ventricular mass in cardiac allograft recipients.
Doesch AO; Ammon K; Konstandin M; Celik S; Kristen A; Frankenstein L; Buss S; Hardt S; Sack FU; Katus HA; Dengler TJ
Transplantation; 2009 Sep; 88(6):835-41. PubMed ID: 19920784
[TBL] [Abstract][Full Text] [Related]
4. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
Doesch AO; Celik S; Ehlermann P; Frankenstein L; Zehelein J; Koch A; Katus HA; Dengler TJ
Transplantation; 2007 Oct; 84(8):988-96. PubMed ID: 17989604
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of metoprolol, ivabradine, and its combination in the management of inappropriate sinus tachycardia in coronary artery bypass graft patients.
Bhatt P; Bhavsar N; Naik D; Shah D
Indian J Pharmacol; 2021; 53(4):264-269. PubMed ID: 34414903
[TBL] [Abstract][Full Text] [Related]
6. Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy.
Ptaszynski P; Kaczmarek K; Ruta J; Klingenheben T; Wranicz JK
Europace; 2013 Jan; 15(1):116-21. PubMed ID: 22772053
[TBL] [Abstract][Full Text] [Related]
7. Effects of ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia.
Zhang R; Haverich A; Strüber M; Simon A; Pichlmaier M; Bara C
Clin Res Cardiol; 2008 Nov; 97(11):811-9. PubMed ID: 18648727
[TBL] [Abstract][Full Text] [Related]
8. Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study.
Doesch AO; Mueller S; Erbel C; Gleissner CA; Frankenstein L; Hardt S; Ruhparwar A; Ehlermann P; Dengler T; Katus HA
Drug Des Devel Ther; 2013; 7():1323-8. PubMed ID: 24235815
[TBL] [Abstract][Full Text] [Related]
9. Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia.
Ptaszynski P; Kaczmarek K; Ruta J; Klingenheben T; Cygankiewicz I; Wranicz JK
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):338-44. PubMed ID: 23426376
[TBL] [Abstract][Full Text] [Related]
10. Lasting reduction of heart transplant tachycardia with ivabradine is effective and well tolerated: results of 48-month study.
Zhang R; Bobylev D; Stiefel P; Haverich A; Bara C
Clin Res Cardiol; 2012 Aug; 101(8):631-6. PubMed ID: 22391988
[TBL] [Abstract][Full Text] [Related]
11. Inappropriate sinus tachycardia in a heart transplant successfully treated with ivabradine.
Mehta N; Bapat A; Tedrow U; Stevenson WG; Koplan B
Europace; 2017 Jul; 19(7):1100. PubMed ID: 28431002
[No Abstract] [Full Text] [Related]
12. The use of ivabradine in a patient with inappropriate sinus tachycardia and cardiomyopathy due to limb girdle muscular dystrophy type 2I.
Rajendram R; AlDhahri F; Mahmood N; Kharal M
BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31969397
[TBL] [Abstract][Full Text] [Related]
13. Effect of Ivabradine on Heart Rate and Duration of Exercise in Patients With Mild-to-Moderate Mitral Stenosis: A Randomized Comparison With Metoprolol.
Saggu DK; Narain VS; Dwivedi SK; Sethi R; Chandra S; Puri A; Saran RK
J Cardiovasc Pharmacol; 2015 Jun; 65(6):552-4. PubMed ID: 25636072
[TBL] [Abstract][Full Text] [Related]
14. Treatment of inappropriate sinus tachycardia with ivabradine.
Rakovec P
Wien Klin Wochenschr; 2009; 121(21-22):715-8. PubMed ID: 19998013
[TBL] [Abstract][Full Text] [Related]
15. Ivabradine is as effective as metoprolol in the prevention of ventricular arrhythmias in acute non-reperfused myocardial infarction in the rat.
Marciszek M; Paterek A; Oknińska M; Mackiewicz U; Mączewski M
Sci Rep; 2020 Sep; 10(1):15027. PubMed ID: 32929098
[TBL] [Abstract][Full Text] [Related]
16. Single dose ivabradine versus intravenous metoprolol for heart rate reduction before coronary computed tomography angiography (CCTA) in patients receiving long-term calcium channel-blocker therapy.
Celik O; Atasoy MM; Ertürk M; Yalçın AA; Aksu HU; Diker M; Aktürk IF; Atasoy I
Acta Radiol; 2014 Jul; 55(6):676-81. PubMed ID: 24052362
[TBL] [Abstract][Full Text] [Related]
17. Ivabradine monotherapy in pediatric patients with focal atrial tachycardia: a single-center study.
Xu X; Guo Y; Gao W; Huang M; Liu T; Li F
Eur J Pediatr; 2023 May; 182(5):2265-2271. PubMed ID: 36869903
[TBL] [Abstract][Full Text] [Related]
18. Successful use of ivabradine in a 10-year-old patient with graft failure after heart transplantation.
Ogawa Y; Urata S; Inuzuka R
Cardiol Young; 2023 Apr; 33(4):649-651. PubMed ID: 35864814
[TBL] [Abstract][Full Text] [Related]
19. Early NT-proBNP decrease with ivabradine in ambulatory patients with systolic heart failure.
Sargento L; Satendra M; Longo S; Lousada N; Palma dos Reis R
Clin Cardiol; 2013 Nov; 36(11):677-82. PubMed ID: 23929789
[TBL] [Abstract][Full Text] [Related]
20. Baseline intrinsic heart rate and response to ivabradine treatment in patients with inappropriate sinus tachycardia.
Kaczmarek K; Klingenheben T; Poddebska I; Urbanek I; Wranicz JK; Cygankiewicz I; Ptaszyński P
Ann Noninvasive Electrocardiol; 2020 May; 25(3):e12709. PubMed ID: 31595620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
